Mechanism of intravenous immune globulin therapy in antibody-mediated autoimmune diseases

New England Journal of Medicine

Volumn 340, Issue 3, 1999, Pages 227-228

  Yu, Zhiya ^a   Lennon, Vanda A ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; METHYLPREDNISOLONE;

ARTICLE; AUTOIMMUNE DISEASE; DRUG MECHANISM; HUMAN; IMMUNOTHERAPY; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; AUTOIMMUNE DISEASES; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULINS, INTRAVENOUS; RECEPTORS, IGG;

EID: 0033590571     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199901213400311     Document Type: Article

References (9)

1. Geha RS, Rosen FS. Intravenous immunoglobulin therapy. In: Austen KF, Burakoff SJ, Rosen FS, Strom TB, eds. Therapeutic immunology. Cambridge, Mass.: Blackwell Science, 1996:280-96.
2. Dalakas MC. Intravenous immune globulin therapy for neurologic diseases. Ann Intern Med 1997;126:721-30.
3. Sell S, Fahey JL. Relationship between γ-globulin metabolism and low serum γ-globulin in germfree mice. J Immunol 1964;93:81-7.
4. Masson PL. Elimination of infectious antigens and increase of IgG catabolism as possible modes of action of IVIg. J Autoimmun 1993;6:683-9.
5. 2-microglobulin-containing neonatal intestinal transport receptor. Proc Nad Acad Sci U S A 1996;93:5512-6.
6. Ghetie V, Ward ES. FcRn: the MHC class I-related receptor that is more than an IgG transporter. Immunol Today 1997;18:592-8.
7. Brambell FWR, Hemmings WA, Morris IG. A theoretical model of γ-globulin catabolism. Nature 1964;203:1352-5.
8. Junghans RP. IgG biosynthesis: no "immunoregulatory feedback." Blood 1997;90:3815-8.
9. Martin MG, Wu SV, Walsh JH. Hormonal control of intestinal Fc receptor gene expression and immunoglobulin transport in suckling rats. J Clin Invest 1993;91:2844-9.